Artykuły udostępnione publicznie: - Adil ButtWięcej informacji
Niedostępne w żadnym miejscu: 2
Comparing outcome of radiofrequency ablation in Barrett’s with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry
RJ Haidry, G Lipman, MR Banks, MA Butt, V Sehgal, D Graham, JM Dunn, ...
Endoscopy 47 (11), 980-987, 2015
Upoważnienia: Cancer Research UK, National Institute for Health Research, UK
Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett’s associated neoplasia
D Kohoutova, R Haidry, M Banks, S Bown, V Sehgal, MA Butt, D Graham, ...
Scandinavian journal of gastroenterology 50 (11), 1315-1321, 2015
Upoważnienia: Cancer Research UK, National Institute for Health Research, UK
Dostępne w jakimś miejscu: 12
Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry
RJ Haidry, JM Dunn, MA Butt, MG Burnell, A Gupta, S Green, H Miah, ...
Gastroenterology 145 (1), 87-95, 2013
Upoważnienia: Cancer Research UK, UK Medical Research Council
Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice
A Mouralidarane, J Soeda, C Visconti‐Pugmire, AM Samuelsson, ...
Hepatology 58 (1), 128-138, 2013
Upoważnienia: UK Biotechnology and Biological Sciences Research Council, British Heart …
Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated …
RJ Haidry, MA Butt, JM Dunn, A Gupta, G Lipman, HL Smart, P Bhandari, ...
Gut 64 (8), 1192-1199, 2015
Upoważnienia: Cancer Research UK, National Institute for Health Research, UK
Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry
RJ Haidry, MA Butt, J Dunn, M Banks, A Gupta, H Smart, P Bhandari, ...
World journal of gastroenterology: WJG 19 (36), 6011, 2013
Upoważnienia: Cancer Research UK, UK Medical Research Council
Development of photodynamic antimicrobial chemotherapy (PACT) for Clostridium difficile
L De Sordi, MA Butt, H Pye, D Kohoutova, CA Mosse, G Yahioglu, ...
PLoS One 10 (8), e0135039, 2015
Upoważnienia: National Institute for Health Research, UK
Warsaw breakage syndrome: Further clinical and genetic delineation
E Alkhunaizi, R Shaheen, SK Bharti, AM Joseph‐George, K Chong, ...
American Journal of Medical Genetics Part A 176 (11), 2404-2418, 2018
Upoważnienia: US National Institutes of Health
Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach
A Rosenfeld, DG Graham, S Jevons, J Ariza, D Hagan, A Wilson, SJ Lovat, ...
The Lancet Digital Health 2 (1), e37-e48, 2020
Upoważnienia: Cancer Research UK, UK Engineering and Physical Sciences Research Council …
Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett’s oesophagus related neoplasia
D Kohoutova, R Haidry, M Banks, MA Butt, J Dunn, S Thorpe, L Lovat
Scandinavian journal of gastroenterology 53 (5), 527-532, 2018
Upoważnienia: Cancer Research UK, National Institute for Health Research, UK
Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate
MA Butt, H Pye, RJ Haidry, D Oukrif, I Puccio, M Gandy, HW Reinert, ...
Oncotarget 8 (15), 25080, 2017
Upoważnienia: Cancer Research UK, UK Medical Research Council, National Institute for …
A HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy
H Pye, MA Butt, HW Reinert, A Maruani, JPM Nunes, JS Marklew, ...
Photochemical & Photobiological Sciences 15, 1227-1238, 2016
Upoważnienia: UK Biotechnology and Biological Sciences Research Council, Cancer Research …
Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression
H Pye, MA Butt, L Funnell, HW Reinert, I Puccio, SUR Khan, S Saouros, ...
Oncotarget 9 (33), 22945, 2018
Upoważnienia: Cancer Research UK, UK Medical Research Council, National Institute for …
Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF‐κB activation in the Barrett metaplasia–dysplasia–adenocarcinoma sequence
I Puccio, S Khan, A Butt, D Graham, V Sehgal, D Patel, M Novelli, ...
International Journal of Experimental Pathology 99 (1), 10-14, 2018
Upoważnienia: National Institute for Health Research, UK
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy